Michael Michaelides

6.0k total citations · 2 hit papers
97 papers, 3.9k citations indexed

About

Michael Michaelides is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, Michael Michaelides has authored 97 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Cellular and Molecular Neuroscience, 22 papers in Molecular Biology and 16 papers in Endocrine and Autonomic Systems. Recurrent topics in Michael Michaelides's work include Neurotransmitter Receptor Influence on Behavior (34 papers), Neuroscience and Neuropharmacology Research (27 papers) and Receptor Mechanisms and Signaling (19 papers). Michael Michaelides is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (34 papers), Neuroscience and Neuropharmacology Research (27 papers) and Receptor Mechanisms and Signaling (19 papers). Michael Michaelides collaborates with scholars based in United States, Spain and Greece. Michael Michaelides's co-authors include Nora D. Volkow, Panayotis K. Thanos, Rubén Baler, Jordi Bonaventura, Gene‐Jack Wang, Juan L. Gomez, Yasmin L. Hurd, Christopher T. Richie, Robert F. Dannals and Martin G. Pomper and has published in prestigious journals such as Science, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Michael Michaelides

94 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemogenetics revealed: DREADD occupancy and activation via converted clozapine

2017 677 citations Juan L. Gomez, Jordi Bonaventura et al. Science profile →
The Neuroscience of Drug Reward and Addiction

2019 468 citations Nora D. Volkow, Michael Michaelides et al. Physiological Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Michaelides United States	32	2.0k	889	838	707	494	97	3.9k
Emilio Merlo‐Pich Italy	32	1.6k 0.8×	1.1k 1.2×	924 1.1×	553 0.8×	901 1.8×	57	4.6k
Colin N. Haile United States	35	2.1k 1.0×	581 0.7×	1.3k 1.5×	530 0.7×	321 0.6×	86	4.0k
Marcelo Febo United States	37	1.4k 0.7×	872 1.0×	829 1.0×	476 0.7×	334 0.7×	161	4.4k
Scott Edwards United States	36	2.5k 1.2×	710 0.8×	1.1k 1.4×	540 0.8×	259 0.5×	115	4.4k
Lynette C. Daws United States	36	2.4k 1.2×	586 0.7×	1.6k 1.9×	338 0.5×	417 0.8×	106	4.1k
Olivier George United States	39	2.6k 1.3×	912 1.0×	1.5k 1.8×	420 0.6×	340 0.7×	111	4.4k
Heath D. Schmidt United States	40	3.0k 1.5×	763 0.9×	1.9k 2.3×	550 0.8×	666 1.3×	86	5.5k
Melanie L. Schwandt United States	39	1.4k 0.7×	585 0.7×	704 0.8×	386 0.5×	411 0.8×	165	4.6k
Wolfgang H. Sommer Germany	46	3.6k 1.8×	1.3k 1.5×	1.8k 2.2×	575 0.8×	449 0.9×	153	6.1k
Kelly Cosgrove United States	36	1.8k 0.9×	835 0.9×	1.5k 1.8×	541 0.8×	194 0.4×	142	5.3k

Countries citing papers authored by Michael Michaelides

Since Specialization

Citations

This map shows the geographic impact of Michael Michaelides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Michaelides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Michaelides more than expected).

Fields of papers citing papers by Michael Michaelides

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Michaelides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Michaelides. The network helps show where Michael Michaelides may publish in the future.

Co-authorship network of co-authors of Michael Michaelides

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Michaelides. A scholar is included among the top collaborators of Michael Michaelides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Michaelides. Michael Michaelides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Çakır, Işın, et al.. (2026). A reversible allosteric inhibitor of GlyT2 for neuropathic pain without on-target side effects. Nature Communications. 17(1).

Michaelides, Michael, et al.. (2025). The dopaminergic effects of esketamine are mediated by a dual mechanism involving glutamate and opioid receptors. Molecular Psychiatry. 30(8). 3443–3454. 3 indexed citations

Clayton, Joseph, Lei Shi, Michael J. Robertson, et al.. (2025). A putative binding model of nitazene derivatives at the μ-opioid receptor. Neuropharmacology. 273. 110437–110437. 2 indexed citations

Levinstein, Marjorie R., Paulo Alexandre de Oliveira, César Quiroz, et al.. (2023). Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone. Molecular Psychiatry. 29(3). 624–632. 7 indexed citations

Solís, Óscar, et al.. (2023). A CRE/DRE dual recombinase transgenic mouse reveals synaptic zinc–mediated thalamocortical neuromodulation. Science Advances. 9(23). eadf3525–eadf3525. 10 indexed citations

Bonaventura, Jordi, Matthew A. Boehm, Hank P. Jedema, et al.. (2023). Expression of the excitatory opsin ChRERα can be traced longitudinally in rat and nonhuman primate brains with PET imaging. Science Translational Medicine. 15(706). eadd1014–eadd1014. 4 indexed citations

Gomez, Juan L., Jacob E. Friedman, Sherry Lam, et al.. (2022). Essential role of P-glycoprotein in the mechanism of action of oliceridine. Neuropsychopharmacology. 48(5). 831–842. 6 indexed citations

Bonaventura, Jordi, Juan L. Gomez, Sherry Lam, et al.. (2022). Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search. Molecular Psychiatry. 27(10). 4144–4156. 27 indexed citations

Bonaventura, Jordi, Sherry Lam, Matthew A. Boehm, et al.. (2021). Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability. Molecular Psychiatry. 26(11). 6704–6722. 178 indexed citations

10.

Gomez, Juan L., Jordi Bonaventura, Jacqueline D. Keighron, et al.. (2021). Synaptic Zn2+ potentiates the effects of cocaine on striatal dopamine neurotransmission and behavior. Translational Psychiatry. 11(1). 570–570. 6 indexed citations

11.

Roseboom, Patrick H., Jonathan A. Oler, Andrew S. Fox, et al.. (2021). Evidence in primates supporting the use of chemogenetics for the treatment of human refractory neuropsychiatric disorders. Molecular Therapy. 29(12). 3484–3497. 22 indexed citations

12.

Galván, Adriana, Jessica Raper, Xing Hu, et al.. (2019). Ultrastructural localization of DREADD s in monkeys. European Journal of Neuroscience. 50(5). 2801–2813. 31 indexed citations

13.

Magnus, Christopher, Peter H. Lee, Jordi Bonaventura, et al.. (2019). Ultrapotent chemogenetics for research and potential clinical applications. Science. 364(6436). 112 indexed citations

14.

Golden, Sam A., Michelle Jin, Conor Heins, et al.. (2019). Nucleus Accumbens Drd1-Expressing Neurons Control Aggression Self-Administration and Aggression Seeking in Mice. Journal of Neuroscience. 39(13). 2482–2496. 64 indexed citations

15.

Volkow, Nora D., Michael Michaelides, & Rubén Baler. (2019). The Neuroscience of Drug Reward and Addiction. Physiological Reviews. 99(4). 2115–2140. 468 indexed citations breakdown →

16.

Klawonn, Anna M., Michael Fritz, Anna Nilsson, et al.. (2018). Motivational valence is determined by striatal melanocortin 4 receptors. Journal of Clinical Investigation. 128(7). 3160–3170. 23 indexed citations

17.

Gomez, Juan L., Jordi Bonaventura, Wojciech G. Lesniak, et al.. (2017). Chemogenetics revealed: DREADD occupancy and activation via converted clozapine. Science. 357(6350). 503–507. 677 indexed citations breakdown →

18.

Thanos, Panayotis K., Lisa S. Robison, John K. Robinson, et al.. (2012). Obese rats with deficient leptin signaling exhibit heightened sensitivity to olfactory food cues. Synapse. 67(4). 171–178. 26 indexed citations

19.

Tsitouridis, Ioannis, et al.. (2008). Early stage of intraperitoneal rupture of Hepatocellular Carcinoma: CT and MRI evaluation. Annals of Gastroenterology. 20(4). 282–286. 4 indexed citations

20.

Thanos, Panayotis K., et al.. (2008). Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions. Synapse. 62(9). 637–642. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact